<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font26">and </span>
   <span class="font16">resistance </span>
   <span class="font15">with </span>
   <span class="font14">drug </span>
   <span class="font14">was </span>
   <span class="font13">for </span>
   <span class="font13">patients </span>
   <span class="font13">were </span>
   <span class="font13">The </span>
   <span class="font13">study </span>
   <span class="font13">HIV- </span>
   <span class="font13">mutations </span>
   <span class="font13">HIV </span>
   <span class="font12">PDR </span>
   <span class="font12">[]. </span>
   <span class="font12">rural </span>
   <span class="font12">urban </span>
   <span class="font12">(), </span>
   <span class="font12">{background </span>
   <span class="font12">from </span>
   <span class="font12">found </span>
   <span class="font11">Pathogens </span>
   <span class="font11">mutation </span>
   <span class="font11">among </span>
   <span class="font11">margin </span>
   <span class="font11">Cameroon </span>
   <span class="font11">Sciences </span>
   <span class="font11">been </span>
   <span class="font11">using </span>
   <span class="font11">CRF_AG </span>
   <span class="font11">Health </span>
   <span class="font11">setting </span>
   <span class="font11">that </span>
   <span class="font11">{border-style </span>
   <span class="font11">are </span>
   <span class="font11">have </span>
   <span class="font11">prevalence </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">ARV </span>
   <span class="font11">Medicine </span>
   <span class="font11">our </span>
   <span class="font11">transcriptase </span>
   <span class="font11">which </span>
   <span class="font11">â€" </span>
   <span class="font11">Biology </span>
   <span class="font11">Drug </span>
   <span class="font11">naÃ¯ve </span>
   <span class="font11">participants </span>
   <span class="font11">sequencing </span>
   <span class="font11">NNRTIs </span>
   <span class="font11">Viral </span>
   <span class="font11">has </span>
   <span class="font11">ART </span>
   <span class="font11">Life </span>
   <span class="font11">both </span>
   <span class="font11">these </span>
   <span class="font11">â€™ </span>
   <span class="font10">Cameroon. </span>
   <span class="font10">Resistance </span>
   <span class="font10">This </span>
   <span class="font10">Viruses </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">settings </span>
   <span class="font10">their </span>
   <span class="font10">this </span>
   <span class="font10">â€". </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">Antiretroviral </span>
   <span class="font10">clinical </span>
   <span class="font10">could </span>
   <span class="font10">detected </span>
   <span class="font10">infected </span>
   <span class="font10">initiating </span>
   <span class="font10">review </span>
   <span class="font10">showed </span>
   <span class="font10">two </span>
   <span class="font10">Immunodeficiency </span>
   <span class="font10">between </span>
   <span class="font10">compared </span>
   <span class="font10">most </span>
   <span class="font10">region </span>
   <span class="font10">reverse </span>
   <span class="font10">study. </span>
   <span class="font10">treatment </span>
   <span class="font10">AIDS </span>
   <span class="font10">Microbial </span>
   <span class="font10">Microbiology </span>
   <span class="font10">WHO </span>
   <span class="font10">[.% </span>
   <span class="font10">genetic </span>
   <span class="font10">level </span>
   <span class="font10">one </span>
   <span class="font10">rate </span>
   <span class="font10">selected </span>
   <span class="font10">transmitted </span>
   <span class="font10">used </span>
   <span class="font10">HIV/AIDS </span>
   <span class="font10">HIV: </span>
   <span class="font10">Organisms </span>
   <span class="font10">Retroviruses </span>
   <span class="font10">al. </span>
   <span class="font10">cells/mm </span>
   <span class="font10">diversity </span>
   <span class="font10">high </span>
   <span class="font10">higher </span>
   <span class="font10">population </span>
   <span class="font10">pre-treatment </span>
   <span class="font10">px; </span>
   <span class="font10">sample </span>
   <span class="font10">sequences </span>
   <span class="font10">strain </span>
   <span class="font10">susceptibility </span>
   <span class="font10">virus </span>
   <span class="font10">{font-family </span>
   <span class="font10">Therapy </span>
   <span class="font10">association </span>
   <span class="font10">conducted </span>
   <span class="font10">fact </span>
   <span class="font10">first-line </span>
   <span class="font10">following </span>
   <span class="font10">font-size </span>
   <span class="font10">method </span>
   <span class="font10">not </span>
   <span class="font10">other </span>
   <span class="font10">presence </span>
   <span class="font10">samples </span>
   <span class="font10">similar </span>
   <span class="font10">studies </span>
   <span class="font10">subtype </span>
   <span class="font10">there </span>
   <span class="font10">viral </span>
   <span class="font10">within </span>
   <span class="font10">(.) </span>
   <span class="font10">National </span>
   <span class="font10">Northwest </span>
   <span class="font10">Our </span>
   <span class="font10">University </span>
   <span class="font10">Urban </span>
   <span class="font10">analysis </span>
   <span class="font10">burden </span>
   <span class="font10">can </span>
   <span class="font10">characteristics </span>
   <span class="font10">diagnosed </span>
   <span class="font10">double; </span>
   <span class="font10">drugs </span>
   <span class="font10">each </span>
   <span class="font10">explained </span>
   <span class="font10">findings </span>
   <span class="font10">had </span>
   <span class="font10">individuals </span>
   <span class="font10">more </span>
   <span class="font10">populations </span>
   <span class="font10">research </span>
   <span class="font10">size </span>
   <span class="font10">than </span>
   <span class="font10">years </span>
   <span class="font10">()] </span>
   <span class="font10">(.% </span>
   <span class="font10">(/)] </span>
   <span class="font10">(â€" </span>
   <span class="font10">./jmv. </span>
   <span class="font10">Africa </span>
   <span class="font10">Cameroon[], </span>
   <span class="font10">Centre </span>
   <span class="font10">Clinical </span>
   <span class="font10">However </span>
   <span class="font10">International </span>
   <span class="font10">Laboratory </span>
   <span class="font10">Med </span>
   <span class="font10">Methods </span>
   <span class="font10">PIs </span>
   <span class="font10">Public </span>
   <span class="font10">RNA </span>
   <span class="font10">Research </span>
   <span class="font10">Sequence </span>
   <span class="font10">Virol. </span>
   <span class="font10">World </span>
   <span class="font10">Yaounde, </span>
   <span class="font10">[IQR: </span>
   <span class="font10">[], </span>
   <span class="font10">accordance </span>
   <span class="font10">also </span>
   <span class="font10">areas </span>
   <span class="font10">blood </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">clade </span>
   <span class="font10">collection </span>
   <span class="font10">drug-naive </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">increase </span>
   <span class="font10">its </span>
   <span class="font10">least </span>
   <span class="font10">may </span>
   <span class="font10">national </span>
   <span class="font10">obtained </span>
   <span class="font10">only </span>
   <span class="font10">original </span>
   <span class="font10">potential </span>
   <span class="font10">results </span>
   <span class="font10">scale-up </span>
   <span class="font10">sequence </span>
   <span class="font10">setting, </span>
   <span class="font10">settings, </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">suggest </span>
   <span class="font10">therapy </span>
   <span class="font10">total </span>
   <span class="font10">viruses </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Î¼l </span>
   <span class="font10">():â€". </span>
   <span class="font10">(.%) </span>
   <span class="font10">(PDR) </span>
   <span class="font10">(n) </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">Available </span>
   <span class="font10">BIYA </span>
   <span class="font10">CRF_cpx </span>
   <span class="font10">Central </span>
   <span class="font10">Defic </span>
   <span class="font10">FokamJ, </span>
   <span class="font10">HAART </span>
   <span class="font10">However, </span>
   <span class="font10">Human </span>
   <span class="font10">Immune </span>
   <span class="font10">Infect </span>
   <span class="font10">Lentivirus </span>
   <span class="font10">Lentivirus: </span>
   <span class="font10">Medical </span>
   <span class="font10">Mutations </span>
   <span class="font10">NRTIs </span>
   <span class="font10">Pathology </span>
   <span class="font10">Reference </span>
   <span class="font10">Res </span>
   <span class="font10">Rural </span>
   <span class="font10">Stanford </span>
   <span class="font10">Viruses: </span>
   <span class="font10">West </span>
   <span class="font10">after </span>
   <span class="font10">against </span>
   <span class="font10">amongst </span>
   <span class="font10">any </span>
   <span class="font10">at: </span>
   <span class="font10">available </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">cell </span>
   <span class="font10">conferring </span>
   <span class="font10">courier; </span>
   <span class="font10">distribution </span>
   <span class="font10">drug-resistance </span>
   <span class="font10">effect </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">epidemiological </span>
   <span class="font10">especially </span>
   <span class="font10">exposed </span>
   <span class="font10">first </span>
   <span class="font10">found. </span>
   <span class="font10">four </span>
   <span class="font10">health </span>
   <span class="font10">help </span>
   <span class="font10">human </span>
   <span class="font10">implications </span>
   <span class="font10">inhibitors </span>
   <span class="font10">low </span>
   <span class="font10">moderate </span>
   <span class="font10">newly </span>
   <span class="font10">occurrence </span>
   <span class="font10">pol </span>
   <span class="font10">pol), </span>
   <span class="font10">predominant </span>
   <span class="font10">prevention </span>
   <span class="font10">program </span>
   <span class="font10">protease </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">recombinant </span>
   <span class="font10">resistant </span>
   <span class="font10">second </span>
   <span class="font10">settings. </span>
   <span class="font10">some </span>
   <span class="font10">staging </span>
   <span class="font10">sub-Saharan </span>
   <span class="font10">subtypes </span>
   <span class="font10">then </span>
   <span class="font10">type </span>
   <span class="font10">under </span>
   <span class="font10">variants </span>
   <span class="font10">version </span>
   <span class="font10">would </span>
  </p>
 </body>
</html>
